Table 1 Characterization of the AD patients and healthy controls
|  | N | Gender F/M | Age (years) | SCORADa | Rhino-conjunctivitis and/or asthma current or history | Total plasma IgEb ≥ 122 kU/L | Total plasma IgEb (kU/L) | Phadiatop positivec |
|---|---|---|---|---|---|---|---|---|
n (% F) | Median (range) | Median (range) | n (%) | n (%) | Median (range) | n (%) | ||
AD patients | 173 | 99/74 (57) | 28 (18–65) | 34 (14–70) | 139 (80) | 95 (55) | 160 (2–15,100) | 132 (76) |
 Severea | 50 | 17/33 (34) | 29 (18–65) | 54 (41–70) | 45 (90) | 35 (70) | 460 (2.5–15,100) | 43 (86) |
 Moderatea | 123 | 82/41 (67) | 28 (18–63) | 31 (14–40) | 94 (76) | 60 (49) | 120 (2–6810) | 89 (72) |
Healthy controls | 84 | 52/32 (62) | 39 (18–65) | NA | 0 (0) | 0 (0) | 19 (2–120) | 0 (0) |